Circulating levels of cytokines and risk of cardiovascular disease: a Mendelian randomization study

Tao Wei1, Zhanfang Zhu2, Lin Liu1

  • 1Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China.

PubMed

Insights

Mendelian randomization revealed causal links between specific cytokines and cardiovascular diseases like coronary artery disease and heart failure. These findings suggest novel therapeutic targets for preventing and treating cardiovascular conditions.

Area of Science:

  • Immunology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Circulating cytokines are linked to cardiovascular disease (CVD), but causality remains unclear.
  • Bias may confound observational associations between cytokines and CVD.
  • Mendelian randomization (MR) is used to investigate causal relationships.

Purpose of the Study:

  • To systematically investigate the causal effects of circulating cytokine levels on CVD development using MR.
  • To determine if genetic predisposition to cytokine levels causally influences CVD risk.

Main Methods:

  • Leveraged genome-wide association study (GWAS) summary statistics for 47 cytokines and four CVD types.
  • Employed a two-sample MR design using cis-quantitative trait loci (cis-QTL) as instrumental variables.
  • Conducted comprehensive sensitivity analyses to ensure result robustness.

Main Results:

  • Identified causal effects of IL-1ra, MCSF, SeSelectin, and SCF on coronary artery disease (CAD) risk.
  • Found causal links between IL-2ra and IP-10 with heart failure (HF), and MCP-3 and SeSelectin with atrial fibrillation (AF).
  • cis-expression QTL (cis-eQTL) analysis revealed additional associations for CAD, HF, and AF, with no significant findings for stroke.

Conclusions:

  • Provides evidence that genetic predisposition to certain cytokine levels causally affects specific CVD development.
  • Highlights potential novel therapeutic strategies targeting cytokines for CVD prevention and treatment.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
56
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15